|
|
|
By Tom von Gunden, chief editor, Drug Delivery Leader | Videocast guest Rob Henson from Sanner US discusses injection delivery technologies for targeting chronic ophthalmic conditions. Topics include patient safety, device ease-of-use, and dose sizing in solid and liquid formulations. | |
|
|
FDA Expectations For Combination Products Part 4 cGMP Summaries | By Doug Mead, CP Pathways LLC | In this article, consultant Doug Mead reports on precedent research into FDA databases on 21 CFR Subpart cGMPs for combination products. He offers sound advice on how to approach summaries submitted for BLA and NDA purposes. |
|
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
